MASS · Company research

908 Devices Inc. Common Stock (MASS): Stock News & Events

Recent company-linked news records available in the database.

RESEARCH CONTEXT

Understand the numbers

Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.

16records availableHealthcare

Stock News & Events data

Database-backed records only

16 rows
titlesummaryurlsourcepublished atsentimentsentiment scorerelevance score
Rivian Stock Gains As EV Maker Gears To Share Pricing Details On Its Upcoming Mass-Market SUV - StocktwitsRivian Stock Gains As EV Maker Gears To Share Pricing Details On Its Upcoming Mass-Market SUV StocktwitsView source ↗StocktwitsOct 16, 2026neutral00.6
Tesla Showcases ‘Flying’ Roadster: Will 2028 Mass Production Boost TSLA Stock? - TradingKeyTesla Showcases ‘Flying’ Roadster: Will 2028 Mass Production Boost TSLA Stock? TradingKeyView source ↗TradingKeyOct 16, 2026neutral00.6
CXMT entered mass production and CXMT Corporation stock sits 23.17 percent below its high - ad-hoc-news.deCXMT entered mass production and CXMT Corporation stock sits 23.17 percent below its high ad-hoc-news.deView source ↗ad-hoc-news.deOct 14, 2026neutral00.6
908 Devices Stock Price Forecast. Should You Buy MASS? - StockInvest.us908 Devices Stock Price Forecast. Should You Buy MASS? StockInvest.usView source ↗StockInvest.usOct 9, 2026neutral00.6
A director sold 30,000 shares at an average $11.89 each at 908 Devices (MASS). - Stock TitanA director sold 30,000 shares at an average $11.89 each at 908 Devices (MASS). Stock TitanView source ↗Stock TitanOct 9, 2026neutral00.6
Under a trading plan, 908 Devices (MASS) CFO Griffith sold 5,000 shares at $13.03 each. - Stock TitanUnder a trading plan, 908 Devices (MASS) CFO Griffith sold 5,000 shares at $13.03 each. Stock TitanView source ↗Stock TitanOct 8, 2026neutral00.6
Xanadu Quantum Stock Jumps on GlobalFoundries Pact to Mass-Produce Computers - Barron'sXanadu Quantum Stock Jumps on GlobalFoundries Pact to Mass-Produce Computers Barron'sView source ↗Barron'sOct 6, 2026neutral00.6
An officer proposes selling 5,000 shares of 908 Devices (NASDAQ: MASS), valued at $64,000. - Stock TitanAn officer proposes selling 5,000 shares of 908 Devices (NASDAQ: MASS), valued at $64,000. Stock TitanView source ↗Stock TitanOct 6, 2026neutral00.6
How New Mass Spectrometry Workflows Will Impact Bruker Stock (BRKR) - Simply Wall StreetHow New Mass Spectrometry Workflows Will Impact Bruker Stock (BRKR) Simply Wall StreetView source ↗Simply Wall StreetOct 4, 2026neutral00.6
Biotech Stocks At 52-Week Highs - KOD, MASS, OBIO, CDNA, PMVP - RTTNewsBiotech Stocks At 52-Week Highs - KOD, MASS, OBIO, CDNA, PMVP RTTNewsView source ↗RTTNewsOct 2, 2026neutral00.6
China’s CXMT shares rise as new DRAM platform enters mass production - Investing.comChina’s CXMT shares rise as new DRAM platform enters mass production Investing.comView source ↗Investing.comSep 21, 2026neutral00.6
RIVN Stock Continues To Slide On Ramp Concerns For Rivian’s Mass-Market EV - StocktwitsRIVN Stock Continues To Slide On Ramp Concerns For Rivian’s Mass-Market EV StocktwitsView source ↗StocktwitsSep 16, 2026neutral00.6
908 Devices Inc. (MASS) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance908 Devices Inc. (MASS) Reports Q2 Loss, Tops Revenue Estimates Yahoo FinanceView source ↗Yahoo FinanceAug 11, 2026neutral00.6
$MASS stock is up 10% today. Here's what we see in our data. - Quiver Quantitative$MASS stock is up 10% today. Here's what we see in our data. Quiver QuantitativeView source ↗Quiver QuantitativeJul 29, 2026neutral00.6
$MASS stock is up 10% today. Here's what we see in our data. - Quiver Quantitative$MASS stock is up 10% today. Here's what we see in our data. Quiver QuantitativeView source ↗Quiver QuantitativeJul 29, 2026neutral00.6
With Its First Mass-Market Vehicle Launching, Is Rivian Stock Ready To Turn The Corner? - TrefisWith Its First Mass-Market Vehicle Launching, Is Rivian Stock Ready To Turn The Corner? TrefisView source ↗TrefisJul 2, 2026neutral00.6

Informational research only, not financial advice. Forecasts are uncertain and can be wrong.